Pro Share Advisors LLC Palatin Technologies Inc Transaction History

Pro Share Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 03, 2020	SELL	$0.41 - $0.73 $5,459 - $9,720	-13,316 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.36 - $0.79 $6,349 - $13,934	-17,638 Reduced 56.98%	13,316 $6,000
Q4 2019 Feb 12, 2020	BUY	$0.75 - $0.89 $5,925 - $7,031	7,900 Added 34.27%	30,954 $24,000
Q3 2019 Nov 12, 2019	BUY	$0.78 - $1.09 $1,236 - $1,727	1,585 Added 7.38%	23,054 $21,000
Q2 2019 Aug 13, 2019	SELL	$0.98 - $1.64 $554 - $928	-566 Reduced 2.57%	21,469 $25,000
Q1 2019 May 15, 2019	BUY	$0.67 - $1.01 $457 - $689	683 Added 3.2%	22,035 $22,000
Q4 2018 Feb 14, 2019	SELL	$0.63 - $1.0 $1,831 - $2,907	-2,907 Reduced 11.98%	21,352 $15,000
Q3 2018 Nov 14, 2018	SELL	$0.88 - $1.1 $1,391 - $1,739	-1,581 Reduced 6.12%	24,259 $24,000
Q2 2018 Aug 13, 2018	BUY	$0.91 - $1.45 $23,514 - $37,468	25,840 New	25,840 $25,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $7.34M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.